coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Sevenoaks PCN, Sevenoaks · Health Inequalities Profile

    PCN U24481 · NHS Kent and Medway Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    84,760

    Registered population

    56.9% aged 18–64

    21.4%

    Aged 65+

    ICB 19.9% · England 17.9%

    6.9%

    Ethnic minority (non-White)

    2.7% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    13,115

    Hypertension register

    +5.84% in 3 yrs · England +5.60%

    643

    SMI register

    70.6% of Sevenoaks'

    1,217

    COPD register

    Reviews +0.74% in 3 yrs

    Forecast to 2030

    15,299

    Hypertension patients, 2030

    +2,184 on today

    65.7%

    QRISK ≥20% on statins, 2030

    +2.31pp over 3 yrs

    6.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    61.3%
    Annual asthma reviews trail England.

    Annual reviews reached 61.3% (England 65.7%), leaving a scale indicator of about 1,900 unreviewed patients across the 4,945 register, which recall could address.

    88.2%
    Preschool MMR second-dose coverage misses target.

    Age 5 MMR2 coverage is 88.2%, below the 95.0% target by 6.8 pp and 7.3 pp behind first-dose uptake at 95.5%.

    85.3%
    Strong blood pressure checks in SMI.

    Across 70.6% of Sevenoaks's SMI register, 85.3% had an annual blood pressure check, above NHS Kent and Medway ICB (79.7%) and England (83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A higher 21.4% share aged 65+ may increase PCN frailty and care demand

    Across 84,760 registered patients, 21.4% (18,122) are aged 65+, above Sevenoaks (19.7%), the ICB (19.9%), and England (17.9%). Children aged 0-17 comprise 21.7% (18,381 patients), matching Sevenoaks (21.7%) and above the ICB (20.7%) and England (19.6%). Census data shows 93.1% are White (Sevenoaks 92.1%, ICB 88.6%, England 81.1%), with an ethnic minority share of 6.9%, including Asian residents at 2.7% (Sevenoaks 2.9%, ICB 4.7%, England 9.6%). These dual cohorts may increase concurrent demand for frailty support and paediatric services, though Census resident bases differ from GP registers.

    Age profile

    0–1721.7%
    18–6456.9%
    65+21.4%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White93.1%
    Asian2.7%
    Mixed2.7%
    Black0.8%
    Other0.7%

    Older people · falls rows are Sevenoaks local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Sevenoaks LA)2,2622,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.5%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Sevenoaks LA)1,1549819552024/25
    Falls deaths, all ages, per 100,000 (Sevenoaks LA)15.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    No registered patients live in Core20 areas, with average deprivation at decile 7.5

    Sevenoaks PCN records an average IMD decile of 7.5 (Sevenoaks 6.7, NHS Kent and Medway ICB 5.4, England 5.5), with 0.0% of registered patients in Core20 areas (Sevenoaks 4.4%, NHS Kent and Medway ICB 17.1%, England 21.0%). Practice averages range from decile 5.9 at Edenbridge Med Practice to 8.6 at South Park Medical Practice, yielding an estimate of 0 Core20 patients. Because area indices identify zero Core20 patients, inequalities outreach could focus on individual inclusion health and vulnerable clinical cohorts.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Amherst Medical0.0% · 0 patients
    Edenbridge Med0.0% · 0 patients
    Westerham0.0% · 0 patients
    Town0.0% · 0 patients
    Borough Green0.0% · 0 patients
    Otford Medical0.0% · 0 patients
    St John's Medical0.0% · 0 patients
    South Park0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    643

    SMI register

    0.75% recorded prevalence

    300

    Learning disability register

    0.35% recorded prevalence

    22

    Care homes, 1,173 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Sevenoaks, Census 2021

    The PCN records 643 severe mental illness patients (70.6% of the borough) and 300 learning disability patients (69.1% of the borough; prevalence 0.3% vs England 0.6%). Catchment services include 22 care homes with 1,173 beds. Sevenoaks borough records an 8.7% unpaid care rate (PCN ceiling estimate 7,374) and 6 autumn 2025 rough sleepers. Lower recorded prevalence may reflect coding or case-finding differences, which practice register validation would test.

    Severe mental illness: physical health checks

    Across 643 SMI patients, 85.3% had a blood pressure check (England 83.4%) and 83.1% had a BMI check (England 82.1%). Over three years, BMI recording rose +3.3 pp (England +5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    13,115

    Hypertension register

    +5.84%

    Register growth, 3 yrs

    Sevenoaks +14.96% · England +5.60%

    +2.14pp

    BP control, under 80

    ≤140/90 · +0.33pp aged 80+

    +2,184

    More patients by 2030

    Forecast 15,299 (17.10%)

    Hypertension case-finding and control

    Hypertension prevalence is 15.3% (13,115 patients), below Sevenoaks (16.6%) and NHS Kent and Medway ICB (16.2%), but in line with England (15.2%), though crude and not age-adjusted. Blood pressure control trails comparators: 64.2% of hypertensive patients under 80 are controlled to <= 140/90 mmHg (Sevenoaks 64.1%, ICB 64.6%, England 67.8%), while 76.9% aged 80+ meet <= 150/90 mmHg (Sevenoaks 77.9%, ICB 78.3%, England 81.2%), and overall control reaches 67.4% (Sevenoaks 68.0%, ICB 67.7%, England 70.3%). With blood pressure control below national rates, the PCN could prioritise systematic recall audits and treatment titration for uncontrolled hypertensive patients.

    Lipids and statins

    Uptake of lipid-lowering therapy is 60.8% for QRISK >= 20% (Sevenoaks 60.3%, ICB 61.4%, England 63.6%), 65.1% in CKD (Sevenoaks 64.6%, England 70.3%), and 69.5% in diabetes without CVD (England 73.2%). Fewer at-risk patients receive lipid-lowering therapy than England rates, indicating an opportunity to prioritise primary-prevention statin recall audits.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026147,643£1.70£1.90£1.86£250,993
    Cardiovascular (all), 2025189,751£2.66£3.57£3.33£504,738

    In 2026, lipid-regulating drugs accounted for 147,643 items at £1.70 per item (Sevenoaks £1.68, England £1.86, ICB £1.90), spending £23,623 less than at England's unit cost. This unit-cost indicator reflects lower expenditure per item than national rates, though unit cost does not evaluate prescribing efficiency or patient case-mix.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +6.31%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.57%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.1% (4,945 patients; Sevenoaks 6.1%, England 6.6%). Annual reviews reached 61.3% (England 65.7%), leaving about 1,900 patients unreviewed. COPD prevalence is 1.4% (1,217 patients; England 1.9%), with 3-year change of -1.7% (England +2.6%) and an unadjusted benchmark gap of +171 to +389 patients. Annual COPD reviews reached 72.8% (England 76.4%). Slower review rates may reflect recall gaps, which practice audits could test.

    Cancer register and children's immunisation

    Cancer prevalence is 5.1% (4,361 patients), above England (3.8%). In childhood immunisation, 6-in-1 uptake at 12 months reached 95.3% and age 5 MMR dose 1 reached 95.5%, both meeting the 95.0% target. However, age 5 MMR dose 2 drops to 88.2%, below the 95.0% target by 6.8 pp and reflecting a 7.3 pp second-dose drop-off. Timely primary uptake is not sustained for preschool boosters.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.3%

    England 91.0%

    6-in-1 complete primary course at 24 months97.8%

    England 92.2%

    MMR dose 1 at 24 months94.1%

    England 88.3%

    MMR dose 2 at age 588.2%

    England 82.8%

    4-in-1 pre-school booster at age 590.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of known-stage cancers across NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384; England 55.3%), below the 75.0% national ambition by 2028. Known-stage coverage was 63.6% (8,384 of 13,189; England 67.0%). Reaching the ambition requires about 1,630 (1,627) extra early-stage diagnoses annually across the ICB, with bowel (48.2%) and lung (29.4%) furthest behind. Sevenoaks PCN recorded 5.1% cancer prevalence (+11.3% over three years) and 74.4% cervical screening coverage (England 66.8%). Screening variation, including 63.0% cervical coverage at St John's Medical Practice, suggests practice recall audits could support earlier detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For Maidstone and Tunbridge Wells NHS Trust, cancer performance was 2.4 pp above the 85.0% 62-day referral to treatment standard, 6.8 pp above the 75.0% 28-day faster diagnosis standard, and 2.3 pp above the 96.0% 31-day combined treatment standard. Across NHS Kent and Medway Integrated Care Board, 62-day referral to treatment and the 31-day combined standard trailed their standards, while the 28-day faster diagnosis standard was 1.8 pp above 75.0%. Timely acute trust access provides strong local pathway support, though wider ICB backlogs could create cross-boundary referral friction.

    Pathways within standard (%)Maidstone and Tunbridge WellsKing's CollegeDartford and GraveshamKent and Medway ICBEngland
    28-day faster diagnosis (75%)81.7880.6878.1476.7879.32
    31-day treatment (96%)98.3596.6897.4895.8492.50
    62-day referral to treatment (85%)87.4370.1563.5975.9371.16
    Diagnostic waits over 6 weeks (%)Maidstone and Tunbridge WellsKing's CollegeDartford and GraveshamEngland
    MRI0.9221.220.3621.40
    CT0.5122.602.089.92
    Echocardiography2.5714.393.9028.48
    Colonoscopy19.8041.810.4030.83
    Gastroscopy24.0335.980.0029.02
    All 15 DM01 tests6.4219.158.3723.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In Sevenoaks borough (wider system, not PCN level), adults aged 65 and over accounted for 65.8% of all community service contacts among borough residents, representing 138,250 of 210,170 total contacts in the provisional June 2026 dataset. This borough-level activity reflects high community care usage among older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient experience varies by 22.4 pp while vaccination achievement spans 78.4 pp

    In 2025/26, overall QOF achievement was 92.5% in England. Practice achievement ranged from 76.7% at St John's Medical Practice to 99.3% at South Park Medical Practice. Vaccination and immunisation achievement varied by 78.4 pp, with Town Medical Centre recording 15.6% (England 55.2%) and South Park Medical Practice achieving 94.0%. Practice audits would test whether variation reflects recall differences.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Town1040.075.0%78.9%89.9%
    Borough Green1160.073.9%51.7%88.5%
    Amherst Medical1030.059.6%70.2%86.4%
    Edenbridge Med990.045.1%77.4%85.4%
    South Park990.050.1%70.7%70.1%
    Westerham Practice1140.056.3%74.3%69.9%
    Otford Medical990.059.5%69.7%69.2%
    St John's Medical1270.040.2%64.5%67.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSevenoaksAssetPCNSevenoaks
    Care homes (catchment)22 (1,173 beds)n/aSchools (catchment)93n/a
    Children's centres35Places of worship8786
    Libraries911Day centres (VCS)311
    Children and young people (VCS)12Carers support groups (VCS)23
    Primary schools (LA maintained)2624Primary academies812
    Special schools21

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Preschool MMR second-dose recall

    Age-5 MMR2 coverage is 88.2% across 220 children (6.8 pp below the 95.0% target; 7.3 pp below MMR1 at 95.5%), with drops of 35.8 pp at Town Medical Centre and 15.8 pp at St John's Medical Practice. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Structured annual asthma review recall

    Annual asthma reviews reached 61.3% (Sevenoaks 58.8%, ICB 60.4%, England 65.7%) across the 4,945 register (prevalence 6.1%), leaving a scale indicator of 1,915 (about 1,900) unreviewed patients. For discussion: the PCN could run a single asthma review template alongside inhaler prescribing checks and offer after-school or holiday review slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    COPD register validation and recall

    COPD prevalence is 1.4% (1,217 patients) vs Sevenoaks 1.6% and England 1.9% (3-year change -1.7% vs England +2.6%), an unadjusted gap of +171 to +389; annual reviews are 72.8% (England 76.4%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Inclusion health outreach targeting (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check review (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension control recall audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall review (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Preschool MMR second-dose recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · COPD register validation and recall (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15